Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

VEGF gel increases hair growth but may have potential toxicity.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

Topical corticosteroid treatment showed no significant difference from placebo in treating alopecia areata in children.

Estheticians in dermatology improve patient satisfaction and loyalty with proper training and planning.

Hair care products with placental growth factor can improve hair thickness and density in postpartum hair loss.

There is not enough evidence to know if different ways of putting in eye drops for glaucoma work better than others.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Hair care practices and concerns about maintaining hairstyles can reduce how often African American women exercise.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Fusion proteins can protect hair from heat damage.

Jojoba oil has many uses beyond skincare, including health benefits and pharmaceutical applications.

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Minoxidil solution had low effect, causing 99% to stop using it.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Different sebaceous gland diseases can be treated with medications, hormone therapy, or surgical methods.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.